Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Borrelia burgdorferi | 27 | 2024 | 28 | 7.470 |
Why?
|
| Bacterial Outer Membrane Proteins | 32 | 2024 | 94 | 6.170 |
Why?
|
| Lyme Disease | 21 | 2023 | 26 | 3.260 |
Why?
|
| Lipoproteins | 24 | 2023 | 95 | 2.610 |
Why?
|
| Borrelia burgdorferi Group | 18 | 2023 | 19 | 2.310 |
Why?
|
| Bacterial Proteins | 24 | 2024 | 474 | 2.210 |
Why?
|
| Antigens, Bacterial | 19 | 2020 | 159 | 1.660 |
Why?
|
| Biomedical Research | 2 | 2022 | 93 | 1.190 |
Why?
|
| Blood Bactericidal Activity | 4 | 2011 | 7 | 0.960 |
Why?
|
| Gene Expression Regulation, Bacterial | 13 | 2021 | 152 | 0.940 |
Why?
|
| Amino Acid Sequence | 20 | 2024 | 674 | 0.840 |
Why?
|
| Mentoring | 1 | 2022 | 10 | 0.800 |
Why?
|
| Complement Factor H | 7 | 2017 | 14 | 0.770 |
Why?
|
| Virulence Factors | 4 | 2021 | 45 | 0.770 |
Why?
|
| Porins | 3 | 2016 | 10 | 0.720 |
Why?
|
| Protein Binding | 8 | 2024 | 636 | 0.660 |
Why?
|
| Membrane Proteins | 7 | 2012 | 467 | 0.610 |
Why?
|
| Antibodies, Bacterial | 11 | 2020 | 100 | 0.540 |
Why?
|
| Plasmids | 8 | 2003 | 122 | 0.500 |
Why?
|
| Treponema pallidum | 10 | 1997 | 12 | 0.490 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 19 | 0.490 |
Why?
|
| Faculty, Medical | 1 | 2015 | 51 | 0.470 |
Why?
|
| Molecular Sequence Data | 22 | 2012 | 1036 | 0.450 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2005 | 190 | 0.410 |
Why?
|
| Immune Evasion | 1 | 2012 | 7 | 0.400 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 53 | 0.380 |
Why?
|
| Protein Domains | 2 | 2024 | 51 | 0.360 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 89 | 0.360 |
Why?
|
| Humans | 25 | 2023 | 27115 | 0.360 |
Why?
|
| Protein Sorting Signals | 3 | 2003 | 18 | 0.360 |
Why?
|
| Complement System Proteins | 2 | 2009 | 24 | 0.340 |
Why?
|
| Blood Physiological Phenomena | 1 | 2009 | 2 | 0.330 |
Why?
|
| Protein Structure, Tertiary | 4 | 2016 | 283 | 0.320 |
Why?
|
| Antigens, Surface | 7 | 2013 | 39 | 0.310 |
Why?
|
| Animals | 24 | 2021 | 10078 | 0.310 |
Why?
|
| Ixodes | 4 | 2021 | 4 | 0.290 |
Why?
|
| Mice, Inbred C3H | 10 | 2021 | 69 | 0.280 |
Why?
|
| Open Reading Frames | 7 | 2012 | 37 | 0.270 |
Why?
|
| Transcription Factors | 2 | 2001 | 512 | 0.260 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 68 | 0.260 |
Why?
|
| Oklahoma | 2 | 2022 | 978 | 0.250 |
Why?
|
| Genome, Bacterial | 4 | 2016 | 68 | 0.250 |
Why?
|
| Carrier Proteins | 3 | 2023 | 246 | 0.240 |
Why?
|
| Mice | 14 | 2021 | 4472 | 0.240 |
Why?
|
| Protein Conformation | 3 | 2015 | 253 | 0.230 |
Why?
|
| Protein Multimerization | 2 | 2015 | 53 | 0.230 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 156 | 0.220 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 1405 | 0.210 |
Why?
|
| Glycolipids | 1 | 2023 | 18 | 0.210 |
Why?
|
| Models, Molecular | 2 | 2015 | 445 | 0.210 |
Why?
|
| Antigenic Variation | 1 | 2002 | 3 | 0.200 |
Why?
|
| Base Sequence | 15 | 2005 | 573 | 0.200 |
Why?
|
| Mentors | 1 | 2022 | 31 | 0.200 |
Why?
|
| Faculty | 1 | 2022 | 61 | 0.190 |
Why?
|
| Lipase | 1 | 2021 | 10 | 0.190 |
Why?
|
| Protein Transport | 2 | 2016 | 153 | 0.190 |
Why?
|
| Gene Targeting | 2 | 2020 | 17 | 0.180 |
Why?
|
| Genetic Complementation Test | 2 | 2020 | 24 | 0.180 |
Why?
|
| Borrelia | 1 | 2000 | 1 | 0.180 |
Why?
|
| Immunoblotting | 4 | 2011 | 123 | 0.180 |
Why?
|
| Genes, Bacterial | 8 | 2005 | 106 | 0.180 |
Why?
|
| Microbial Viability | 2 | 2011 | 28 | 0.170 |
Why?
|
| Laminin | 1 | 2020 | 21 | 0.170 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 481 | 0.170 |
Why?
|
| Gene Expression | 3 | 2020 | 408 | 0.170 |
Why?
|
| Fatty Acids | 1 | 2021 | 201 | 0.170 |
Why?
|
| Cell Membrane | 6 | 1997 | 236 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2000 | 229 | 0.160 |
Why?
|
| Sequence Alignment | 3 | 2009 | 110 | 0.160 |
Why?
|
| Liposomes | 2 | 2016 | 142 | 0.160 |
Why?
|
| Complement C3b Inactivator Proteins | 2 | 2011 | 2 | 0.160 |
Why?
|
| Mutation | 3 | 2020 | 818 | 0.150 |
Why?
|
| Gene Expression Profiling | 4 | 2005 | 440 | 0.150 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 11 | 0.150 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 34 | 0.150 |
Why?
|
| Bacterial Vaccines | 5 | 2013 | 28 | 0.150 |
Why?
|
| Escherichia coli Infections | 1 | 2017 | 45 | 0.140 |
Why?
|
| Escherichia coli | 2 | 2017 | 330 | 0.140 |
Why?
|
| Operon | 2 | 2016 | 40 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2013 | 229 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2020 | 331 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 262 | 0.140 |
Why?
|
| Bacteremia | 1 | 2017 | 80 | 0.140 |
Why?
|
| Conserved Sequence | 1 | 2017 | 54 | 0.140 |
Why?
|
| Macrophage Activation | 2 | 1995 | 32 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2017 | 44 | 0.140 |
Why?
|
| Protein Folding | 1 | 2016 | 47 | 0.140 |
Why?
|
| Computing Methodologies | 1 | 2016 | 2 | 0.130 |
Why?
|
| Vaccine Potency | 1 | 2016 | 2 | 0.130 |
Why?
|
| Computer Communication Networks | 1 | 2016 | 4 | 0.130 |
Why?
|
| Consensus | 1 | 2016 | 69 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 201 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2015 | 116 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 11 | 0.120 |
Why?
|
| Permeability | 1 | 2015 | 59 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2011 | 165 | 0.120 |
Why?
|
| Data Collection | 1 | 2015 | 101 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 74 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2002 | 130 | 0.110 |
Why?
|
| Papio | 2 | 2006 | 78 | 0.110 |
Why?
|
| Trypsin | 1 | 2013 | 24 | 0.110 |
Why?
|
| Proteolysis | 1 | 2013 | 55 | 0.110 |
Why?
|
| Algorithms | 1 | 2016 | 422 | 0.110 |
Why?
|
| Gene Knockout Techniques | 2 | 2011 | 35 | 0.100 |
Why?
|
| Rats | 4 | 2006 | 1554 | 0.100 |
Why?
|
| Ticks | 4 | 2008 | 9 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 928 | 0.090 |
Why?
|
| Serum | 1 | 2011 | 9 | 0.090 |
Why?
|
| Immunoassay | 1 | 2011 | 35 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 546 | 0.090 |
Why?
|
| Joints | 1 | 2010 | 12 | 0.090 |
Why?
|
| Steroidogenic Factor 1 | 2 | 2001 | 3 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 24 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2011 | 147 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2001 | 74 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2010 | 118 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2009 | 75 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2001 | 114 | 0.080 |
Why?
|
| Heart | 1 | 2010 | 221 | 0.080 |
Why?
|
| DNA, Bacterial | 5 | 2003 | 302 | 0.080 |
Why?
|
| United States | 1 | 2015 | 2060 | 0.080 |
Why?
|
| Blood Proteins | 2 | 2005 | 64 | 0.080 |
Why?
|
| Octoxynol | 2 | 2006 | 9 | 0.070 |
Why?
|
| Female | 4 | 2021 | 14633 | 0.070 |
Why?
|
| Lyme Disease Vaccines | 1 | 2006 | 1 | 0.070 |
Why?
|
| Cloning, Molecular | 3 | 1996 | 205 | 0.060 |
Why?
|
| Virulence | 3 | 2017 | 144 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2000 | 31 | 0.060 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2005 | 2 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2006 | 39 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2004 | 317 | 0.060 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 408 | 0.060 |
Why?
|
| Temperature | 2 | 2003 | 207 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2006 | 93 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 241 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2005 | 62 | 0.060 |
Why?
|
| Male | 2 | 2021 | 13019 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 79 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 115 | 0.060 |
Why?
|
| Lysine | 1 | 2004 | 71 | 0.060 |
Why?
|
| Iron | 1 | 2005 | 107 | 0.050 |
Why?
|
| Streptococcus | 1 | 2003 | 17 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2003 | 648 | 0.050 |
Why?
|
| Peritoneal Cavity | 2 | 2005 | 13 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2002 | 19 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2004 | 200 | 0.050 |
Why?
|
| Calgranulin B | 1 | 2022 | 17 | 0.050 |
Why?
|
| Quinolones | 1 | 2022 | 22 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2002 | 30 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2011 | 1379 | 0.050 |
Why?
|
| Chemokines | 1 | 2022 | 73 | 0.050 |
Why?
|
| beta Catenin | 1 | 2022 | 62 | 0.050 |
Why?
|
| Biofilms | 1 | 2003 | 119 | 0.050 |
Why?
|
| Cytokines | 2 | 2022 | 440 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2002 | 51 | 0.050 |
Why?
|
| Biological Evolution | 2 | 2000 | 95 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 49 | 0.050 |
Why?
|
| Tick Infestations | 1 | 2001 | 3 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 163 | 0.050 |
Why?
|
| Phenotype | 1 | 2003 | 667 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 325 | 0.040 |
Why?
|
| Protein Structure, Secondary | 2 | 1997 | 130 | 0.040 |
Why?
|
| Syphilis | 2 | 1997 | 3 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1997 | 111 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 278 | 0.040 |
Why?
|
| Vaccination | 2 | 1998 | 175 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 331 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2004 | 65 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 1996 | 26 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 1999 | 13 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1996 | 46 | 0.040 |
Why?
|
| Adhesins, Bacterial | 1 | 1998 | 7 | 0.040 |
Why?
|
| Spirochaetales | 1 | 1998 | 2 | 0.040 |
Why?
|
| Dialysis | 1 | 1998 | 4 | 0.040 |
Why?
|
| Transcription, Genetic | 4 | 2003 | 400 | 0.040 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1997 | 3 | 0.040 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1997 | 15 | 0.040 |
Why?
|
| Azirines | 1 | 1997 | 1 | 0.040 |
Why?
|
| Opsonin Proteins | 1 | 1997 | 5 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 1997 | 42 | 0.040 |
Why?
|
| Thioredoxins | 1 | 1997 | 26 | 0.040 |
Why?
|
| Leucine | 1 | 1997 | 20 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 1998 | 163 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 115 | 0.030 |
Why?
|
| Multigene Family | 1 | 1996 | 50 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1995 | 6 | 0.030 |
Why?
|
| Gene Library | 1 | 1995 | 45 | 0.030 |
Why?
|
| NF-kappa B | 1 | 1996 | 187 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 1995 | 57 | 0.030 |
Why?
|
| Monocytes | 1 | 1996 | 132 | 0.030 |
Why?
|
| Immune Sera | 2 | 2010 | 22 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 2 | 2005 | 37 | 0.030 |
Why?
|
| Endopeptidase K | 2 | 2008 | 4 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 846 | 0.030 |
Why?
|
| Periplasmic Binding Proteins | 1 | 1994 | 1 | 0.030 |
Why?
|
| DNA Primers | 3 | 2002 | 143 | 0.030 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1994 | 23 | 0.030 |
Why?
|
| Culture Media | 2 | 2005 | 97 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 1994 | 60 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 20 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 24 | 0.030 |
Why?
|
| Disulfides | 1 | 1993 | 33 | 0.030 |
Why?
|
| Solubility | 1 | 1993 | 73 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 90 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 239 | 0.030 |
Why?
|
| Rodent Diseases | 1 | 2011 | 4 | 0.020 |
Why?
|
| Histidine Kinase | 1 | 2011 | 10 | 0.020 |
Why?
|
| Molecular Weight | 3 | 1997 | 118 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2011 | 90 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 81 | 0.020 |
Why?
|
| Myocarditis | 1 | 2010 | 21 | 0.020 |
Why?
|
| Macrophages | 1 | 1993 | 279 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2000 | 130 | 0.020 |
Why?
|
| Genomic Library | 2 | 1998 | 10 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 1998 | 50 | 0.020 |
Why?
|
| Peritoneal Dialysis | 1 | 2005 | 4 | 0.020 |
Why?
|
| Freeze Fracturing | 2 | 1995 | 2 | 0.020 |
Why?
|
| Antibiosis | 1 | 2005 | 6 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2004 | 2 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2004 | 17 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 129 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 2004 | 53 | 0.010 |
Why?
|
| Heparin | 1 | 2004 | 110 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 2003 | 29 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 2003 | 65 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 38 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2002 | 22 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 2002 | 11 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 538 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2002 | 45 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 26 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 76 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 74 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 275 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 163 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 448 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1998 | 71 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 14 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1997 | 57 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1998 | 264 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1997 | 20 | 0.010 |
Why?
|
| Peptidoglycan | 1 | 1997 | 47 | 0.010 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 1996 | 11 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1996 | 28 | 0.010 |
Why?
|
| Models, Structural | 1 | 1996 | 13 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1996 | 30 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1996 | 33 | 0.010 |
Why?
|
| Virus Replication | 1 | 1996 | 63 | 0.010 |
Why?
|
| HIV-1 | 1 | 1996 | 54 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1995 | 18 | 0.010 |
Why?
|
| Membrane Lipids | 1 | 1995 | 21 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 94 | 0.010 |
Why?
|
| Acylation | 1 | 1995 | 10 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 1995 | 10 | 0.010 |
Why?
|
| Quinolinium Compounds | 1 | 1995 | 2 | 0.010 |
Why?
|
| Benzoxazoles | 1 | 1995 | 3 | 0.010 |
Why?
|
| Sepharose | 1 | 1995 | 14 | 0.010 |
Why?
|
| Microspheres | 1 | 1995 | 48 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1995 | 89 | 0.010 |
Why?
|
| Cell Movement | 1 | 1996 | 353 | 0.010 |
Why?
|
| Peptides | 1 | 1996 | 280 | 0.010 |
Why?
|
| Serial Passage | 1 | 1994 | 1 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1996 | 976 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 681 | 0.010 |
Why?
|